HIV/AIDS

HIV/AIDS

HIV and ID Observations Blog

Ten Reasons to Attend Our “Infectious Diseases in Primary Care” Course Free

In HIV and ID Observations, Dr. Paul Sax offers 10 reasons why you should attend the “Infectious Diseases in Primary Care” course in Boston this year.

Drug Watch

Dolutegravir

The FDA has approved the integrase inhibitor dolutegravir for treatment of HIV infection, in combination with other antiretrovirals.